Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HYPERTENSION RENAL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT02499185
What this trial is testing

Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients

Who this might be right for
Acute Kidney InjuryArterial HypertensionObesity+4 more
Universitair Ziekenhuis Brussel 100
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Not applicableStudy completedNCT01052220
What this trial is testing

Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention

Who this might be right for
HypertensionHemodialysis
Wayne State University 118
Not applicableStudy completedNCT06744335
What this trial is testing

Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)

Who this might be right for
Rate of CKD Diagnosis in Patients With AH and CKD MarkersDemographic and Clinical Characteristics for Those PatientsRoutine Therapy Before and After the Diagnosis of CKD
AstraZeneca 1,283
Post-approval studies (Phase 4)WithdrawnNCT01302236
What this trial is testing

Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients

Who this might be right for
HypertensionChronic Kidney Disease.
Jichi Medical University
Post-approval studies (Phase 4)Temporarily pausedNCT00369538
What this trial is testing

Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

Who this might be right for
ProteinuriaHypertensionEnd Stage Renal Disease
University Hospital, Strasbourg, France 20
Not applicableStudy completedNCT02039492
What this trial is testing

Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.

Who this might be right for
Resistant Arterial Hypertension
Parc de Salut Mar 38
Not applicableStudy completedNCT03473509
What this trial is testing

Primary Care CKD Registry

Who this might be right for
HypertensionChronic Kidney Diseases
University of California, San Francisco 746
Not applicableLooking for participantsNCT06288204
What this trial is testing

Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseasesHypertensionCardiovascular Diseases
Universidade Federal Fluminense 153
Not applicableStudy completedNCT04037436
What this trial is testing

Functional Exercise and Nutrition Education Program for Older Adults

Who this might be right for
Chronic DiseaseFrailDiabetes Mellitus+9 more
University of Waterloo 44
Post-approval studies (Phase 4)UnknownNCT00719316
What this trial is testing

Aliskiren and Muscle Sympathetic Nerve Activity

Who this might be right for
Chronic Kidney DiseaseHypertensionMuscle Sympathetic Nerve Activity
UMC Utrecht 30
Not applicableStudy completedNCT04761016
What this trial is testing

The Integrated Population (I-POP) Health Trial

Who this might be right for
DiabetesHypertensionChronic Kidney Diseases+2 more
Baylor Research Institute 202
Testing effectiveness (Phase 2)Study completedNCT01371747
What this trial is testing

Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)

Who this might be right for
Chronic Kidney DiseaseHypertensionHyperkalemia
Relypsa, Inc. 324
Not applicableUnknownNCT03478176
What this trial is testing

Intraabdominal Hypertension After Kidney Transplantation

Who this might be right for
Intraabdominal HypertensionKidney Transplantation
CHU de Reims 100
Post-approval studies (Phase 4)Ended earlyNCT03471117
What this trial is testing

Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

Who this might be right for
Chronic Kidney Diseases
The University of Texas at Arlington 5
Not applicableUnknownNCT01832558
What this trial is testing

The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)

Who this might be right for
CKD II-III
Medical University of Vienna 24
Not applicableEnded earlyNCT01887067
What this trial is testing

Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus

Who this might be right for
Hypertension, ResistantDiabetes MellitusRenal Denervation Therapy
Pamela Youde Nethersole Eastern Hospital 7
Not applicableStudy completedNCT04142138
What this trial is testing

When the Kidney Reacts to Nutritional Changes

Who this might be right for
Prehypertension
Rockefeller University 9
Not applicableUnknownNCT04722159
What this trial is testing

Clinical Outcome of Patients With Resistant Hypertension Undergoing Renal Denervation

Who this might be right for
Hypertension, Renal
Vastra Gotaland Region 300
Post-approval studies (Phase 4)Ended earlyNCT02539810
What this trial is testing

Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)

Who this might be right for
HypertensionHypertension Resistant to Conventional TherapyAngiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent
Assistance Publique - Hôpitaux de Paris 4
Next Page